Calnexin antibody
Quick Overview for Calnexin antibody (ABIN6251945)
Target
See all Calnexin (CANX) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Does not react with rat
-
Purification
- Protein G affinity chromatography
-
Immunogen
- A partial human recombinant protein was used as the immunogen for the Calnexin antibody.
-
Isotype
- IgG2b kappa
-
-
-
-
Application Notes
-
WB: 0.5-1 μg/mL
Flow Cytometry: 0.5-1 μg/10^6 cells
Immunofluorescence: 0.5-1 μg/mL
Immunohistochemistry (FFPE): 1-2 μg/mL for 30 min at RT
Titering of the Calnexin antibody may be required for optimal performance. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
-
- Calnexin (CANX)
-
Alternative Name
- Calnexin
-
Background
- It recognizes a protein of 90 kDa, which is identified as Calnexin. Secretory and transmembrane proteins are synthesized on polysomes and translocate into the endoplasmic reticulum (ER) where they are often modified by the formation of disulfide bonds, amino-linked glycosylation and folding. To help proteins fold properly, the ER contains a pool of molecular chaperones including calnexin. It is a calcium-binding, endoplasmic reticulum (ER)-associated protein that interacts transiently with newly synthesized N-linked glycoproteins, facilitating protein folding and assembly. It may also play a central role in the quality control of protein folding by retaining incorrectly folded protein subunits within the ER for degradation.
-
Pathways
- MAPK Signaling, Thyroid Hormone Synthesis
Target
-